Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure

Annals of Thoracic Surgery

Volumn 84, Issue 3, 2007, Pages 729-736

  Dohmen, Pascal M ^a   Lembcke, Alexander ^a   Holinski, Sebastin ^a   Kivelitz, Dietmar ^a   Braun, Jan P ^a   Pruss, Axel ^a   Konertz, Wolfgang ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLOGRAFT; ARTICLE; BIOREACTOR; CELL DENSITY; CELL VIABILITY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HEART RIGHT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VALVE SURGERY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VALVE; SAPHENOUS VEIN; SURVIVAL RATE; TISSUE ENGINEERING; TRANSTHORACIC ECHOCARDIOGRAPHY; XENOGRAFT;

ADULT; BIOPROSTHESIS; CRYOPRESERVATION; ECHOCARDIOGRAPHY, DOPPLER; ENDOTHELIAL CELLS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PULMONARY VALVE; TISSUE ENGINEERING; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR OUTFLOW OBSTRUCTION;

EID: 34548041619     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.04.072     Document Type: Article

References (34)

1. Harken D.E. Heart valves: ten commandments and still counting. Ann Thorac Surg 48 (1989) S18-S19
2. Smith J.D., Ogino H., Hunt D., Laylor R.M., Rose M.L., and Yacoub M.H. Humoral immune response to human aortic valve homografts. Ann Thorac Surg 60 (1995) S127-S130
3. Costa F.D.A., Dohmen P., Duarte D., et al. Immunological and echocardiographic evaluation of decellularized versus cryopreserved homografts during Ross procedure. Eur J Cardiothorac Surg 27 (2005) 572-578
4. Dohmen P.M., da Costa F., Lopes S.V., et al. Is there a possibility for a glutaraldehyde-free porcine heart valve to grow?. Eur Surg Res 38 (2006) 54-61
5. Erdbruegger W., Posner S., Ellerbrock H., et al. Deoxycholic acid treatment offers improved prospects in heart valve replacement. Tissue Eng 8 (2006) 1-11
6. Dohmen P.M., Ozaki S., Verbeken E., Yperman J., Flameng W., and Konertz W. Tissue engineering of a pulmonary xenograft heart valve. Asian Cardiovasc Thoracic Surg 10 (2002) 25-30
7. Dohmen P.M., Kivelitz D., Hotz H., and Konertz W. Ross operation with a tissue engineered heart valve. Ann Thorac Surg 74 (2002) 1438-1442
8. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 284 (2000) 3043-3045
9. Calafiore A.M., Teodori G., Mezzetti A., et al. Intermittent antegrade warm blood cardioplegia. Ann Thorac Surg 59 (1995) 398-402
10. Lembcke A., Dohmen P.M., Dewey M., et al. Multislice computed tomography for preoperative evaluation of right ventricular volumes and function comparison with magnetic resonance imaging. Ann Thorac Surg 79 (2005) 1344-1351
11. Lembcke A., Dohmen P.M., Dewey M., et al. Multislice computed tomography for preoperative evaluation of right ventricular volumes and function comparison with echocardiography. Radiology 236 (2005) 47-55
12. Konertz W., Dohmen P.M., Liu J., et al. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J Heart Valve Dis 14 (2005) 78-81
13. Ross D.N. Replacement of the aortic and mitral valve with a pulmonary autograft. Lancet 2 (1967) 956-958
14. Doss M., Wood J.P., Martens S., Greinecker G., and Moritz A. Do pulmonary autografts provide better outcomes than mechanical valves?. A prospective randomised trial. Ann Thorac Surg 80 (2005) 2194-2198
15. Wang A., Jaggers J., Ungerleider R.M., Lim C.S., and Ryan T. Exercise echocardiographic comparison of pulmonary autograft and aortic homograft replacements for aortic valve disease in adults. J Heart Valve Dis 12 (2003) 202-208
16. Affonso da Costa F.D., Pinton R., Haggi Filho H., et al. The Ross procedure: is it the ideal operation for the young with aortic valve disease?. Heart Surg Forum 1 (1998) 116-124
17. Chambers J.C., Somerville J., Stone S., and Ross D.N. Pulmonary autograft procedure for aortic valve disease. Long-term results of the pioneer series. Circulation 96 (1997) 2206-2214
18. Hoestra F., Knoop C., Jutte N., et al. Effect of cryopreservation and HLA-DR matching on the cellular immunogenicity of human cardiac valve allografts. J Heart Lung Transplant 13 (1994) 1095-1098
19. Baskett R.J., Ross D.B., Nanton M.A., and Murphy D.A. Factors in the early failure of cryopreserved homograft pulmonary valves in children: preserved immunogenicity?. J Thorac Cardiovasc Surg 112 (1996) 1170-1179
20. Rodgers G.M. Hemostatic properties of normal and perturbed vascular cells. FASEB J 2 (1988) 116-123
21. Andrews R.K., and Berndt M.C. Platelet physiology and thrombosis. Thromb Res 114 (2004) 447-453
22. Pascual G., Escudero C., Rodriguez M., et al. Restoring the endothelium of cryopreserved arterial grafts: co-culture of venous and arterial endothelial cells. Cryobiol 49 (2004) 272-285
23. Kasimir M.T., Weigel G., Sharma J., et al. The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost 94 (2005) 462-467
24. Meinhart J.G., Deutsch M., Fischlain T., Howanietz N., Froschl A., and Zilla P. Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE-grafts. Ann Thorac Surg 71 (2001) S327-S331
25. Brockbank K.G., Lightfoort F.G., Song Y.C., and Taylor M.J. Interstitial ice formation in cryopreserved homografts: a possible cause of tissue deterioration and calcification in vivo. J Heart Valve Dis 9 (2000) 200-206
26. Goffin Y.A., Van Hoeck B., Jashari R., Soots G., and Kalmar P. Banking of cryopreserved heart valves in Europe: assessment of a 10-year operation in the European Homograft Bank (EHB). J Heart Valve Dis 9 (2000) 207-214
27. Aidulis D., Pegg D.E., Hunt C.J., et al. Processing of ovine cardiac valve allografts: 1. Effects of preservation method on structure and mechanical properties. Cell Tissue Bank 3 (2002) 79-89
28. Hanke C.W., Higley H.R., Jolivette D.M., Swanson N.A., and Stegman S.J. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 25 (1991) 319-326
29. Mehlisch D.R. Collagen/hydroxylapatite implant for augmenting deficient alveolar ridges: A 24 month clinical and histologic summary. Oral Surg Oral Med Oral Pathol 68 (1989) 505-514
30. Speer D.P., Chvapil M., Eskelson C.D., and Ulreich J. Biological effects of residual glutaraldehyde in glutaraldehyde-tanned collagen biomaterials. J Biomed Mater Res 14 (1980) 753-764
31. Courtman D.W., Errett B.F., and Wilson G.J. The role of crosslinking in modification of the immune response elicited against xenogenic vascular acellular matrices. J Biomed Mater Res 55 (2001) 576-586
32. Dohmen P.M., Ozaki S., Yperman J., Flameng W., and Konertz W. Results of tissue engineered auto-xenograft implanted in the juvenile sheep model. Med Sci Monit 9 (2003) BR97-BR107
33. Simon P., Kasimir M.T., Seebacher G., et al. Early failure of the tissue engineered procine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 23 (2003) 1002-1006
34. Bechtel J.F., Muller-Steinhardt M., Schmidtke C., Brunswik A., Stierle U., and Sievers H.H. Evalualtion of the decelluarized pulmonary valve homograft (SynerGraft). J Heart Valve Dis 12 (2003) 734-739